Condition: Colorectal Cancer · Coffee · Gastrointestinal Microbiome · Sponsor: Massachusetts General Hospital
This is research study is assessing the effects of 6-g daily use of freeze-dried instant coffee on liver fat and fibrosis and the gut microbiome and metabolome in patients who have completed routine treatment (including surgery, chemotherapy and radiotherapy) for stage I-III colorectal cancer.
This description comes directly from the study's public registry record.
Mingyang Song, MD, ScD · (617) 643-3364 · msong2@mgh.harvard.edu
Aparna R Parikh, MD, MS · (617) 726-4000 · APARNA.PARIKH@MGH.HARVARD.EDU
Always discuss trial participation with your own doctor first.
| Massachusetts General Hospital | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05692024